Your session is about to expire
← Back to Search
Communication Training for Family Caregiving
N/A
Waitlist Available
Led By Talia Zaider, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial will provide a communication training program to inpatient nurses and social workers at Memorial Sloan Kettering Cancer Center to help them assist caregiving families.
Who is the study for?
This trial is for nurses and social workers at MSKCC who can attend most training sessions. They'll work with families of inpatient cancer patients, including a designated family friend involved in care. Excluded are those under 12, non-English speakers, or anyone with severe cognitive impairment.Check my eligibility
What is being tested?
The study tests a communication training program called Working with the Caregiving Family (WCF). It aims to improve how healthcare providers support and interact with families of hospitalized cancer patients through didactic and consolidation sessions.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. Participants may experience emotional or psychological responses to the training content.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Provider outcomes
Secondary outcome measures
patient and/or family members'outcomes
Trial Design
1Treatment groups
Experimental Treatment
Group I: Working with the Caregiving Family (WCF) trainingExperimental Treatment2 Interventions
This is a new training curriculum for inpatient oncology providers called Working with the Caregiving Family (WCF) training, a program designed to teach MSKCC inpatient staff to address family-level concerns during acute hospitalization. The WCF training will teach staff to recognize and inquire about areas of family distress that are likely to impact the caregiving process; to provide brief, supportive interventions, and/or to transition families to specialized support services when needed. We will provide staff with skills to address especially challenging family situations (e.g., noncompliance with medical care, conflict, poor communication) in collaborative and compassionate ways. We will teach clinicians to intervene and respond more effectively when problematic relationships develop within families or between families and larger systems (e.g., medical team, institutional programs).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
questionnaires
2008
Completed Phase 2
~3450
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,933 Previous Clinical Trials
585,540 Total Patients Enrolled
Ackerman Institute for FamilyOTHER
Talia Zaider, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
5 Previous Clinical Trials
1,352 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I plan to attend most of the training and consolidation sessions.I am, or have a family member, younger than 12 years old.I or a family member do not speak English.
Research Study Groups:
This trial has the following groups:- Group 1: Working with the Caregiving Family (WCF) training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research study currently accepting new participants?
"Data hosted on clinicaltrials.gov reveals that this research is not presently recruiting participants, as its latest update was made March 1st 2022. However, there are currently 1 other trials actively enrolling patients seeking a similar treatment option."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger